Show simple item record

dc.contributor.authorOropeza, Daniel
dc.contributor.authorCigliola, Valentina
dc.contributor.authorRomero, Agustín
dc.contributor.authorChera, Simona
dc.contributor.authorRodríguez-Seguí, Santiago
dc.contributor.authorHerrera, Pedro L.
dc.date.accessioned2022-04-21T09:00:45Z
dc.date.available2022-04-21T09:00:45Z
dc.date.created2022-01-19T18:21:29Z
dc.date.issued2021
dc.identifier.issn1471-2164
dc.identifier.urihttps://hdl.handle.net/11250/2991872
dc.description.abstractBackground Loss of pancreatic insulin-secreting β-cells due to metabolic or autoimmune damage leads to the development of diabetes. The discovery that α-cells can be efficiently reprogrammed into insulin-secreting cells in mice and humans has opened promising avenues for innovative diabetes therapies. β-cell loss triggers spontaneous reprogramming of only 1–2% of α-cells, limiting the extent of regeneration. Most α-cells are refractory to conversion and their global transcriptomic response to severe β-cell loss as well as the mechanisms opposing their reprogramming into insulin producers are largely unknown. Here, we performed RNA-seq on FAC-sorted α-cells to characterize their global transcriptional responses at different time points after massive β-cell ablation. Results Our results show that α-cells undergo stage-specific transcriptional changes 5- and 15-days post-diphtheria toxin (DT)-mediated β-cell ablation. At 5 days, α-cells transiently upregulate various genes associated with interferon signaling and proliferation, including Interferon Induced Protein with Tetratricopeptide Repeats 3 (Ifit3). Subsequently, at 15 days post β-cell ablation, α-cells undergo a transient downregulation of genes from several pathways including Insulin receptor, mTOR and MET signaling. Conclusions The results presented here pinpoint novel markers discriminating α-cells at different stages after acute β-cell loss, and highlight additional signaling pathways that are modulated in α-cells in this context.en_US
dc.language.isoengen_US
dc.publisherBioMed Centralen_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleStage-specific transcriptomic changes in pancreatic α-cells after massive β-cell lossen_US
dc.typeJournal articleen_US
dc.typePeer revieweden_US
dc.description.versionpublishedVersionen_US
dc.rights.holderCopyright 2021 The Author(s)en_US
dc.source.articlenumber585en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.doi10.1186/s12864-021-07812-x
dc.identifier.cristin1985342
dc.source.journalBMC Genomicsen_US
dc.identifier.citationBMC Genomics. 2021, 22, 585en_US
dc.source.volume22en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Navngivelse 4.0 Internasjonal
Except where otherwise noted, this item's license is described as Navngivelse 4.0 Internasjonal